BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Flexion Therapeutics 

300 TradeCenter
Suite 2460
Woburn  Massachusetts  01801  U.S.A.
Phone: 781-897-9977 Fax: 781-897-9970


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Flexion Therapeutics (FLXN) To Present At The 13th Annual Needham Healthcare Conference 4/2/2014 9:08:00 AM    More...
Flexion Therapeutics (FLXN) Reports Year-End 2013 Financial Results 3/27/2014 9:06:40 AM    More...
Flexion Therapeutics (FLXN) To Report Year-End 2013 Earning Results On March 27, 2014 3/21/2014 8:56:40 AM    More...
Flexion Therapeutics (FLXN) To Present At The 34th Annual Cowen Health Care Conference 2/26/2014 8:57:47 AM    More...
Flexion Therapeutics (FLXN) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 2/19/2014 9:05:44 AM    More...
Flexion Therapeutics (FLXN) Pulls Off $60 Million In IPO Debut 2/12/2014 7:21:44 AM    More...
Flexion Therapeutics (FLXN) Files For $86.25 Million IPO To Develop Osteoarthritis Drugs 1/9/2014 6:40:50 AM    More...
Flexion Therapeutics Presents Robust Phase 2b Data for FX006 at 2013 American College of Rheumatology Annual Scientific Meeting 10/30/2013 7:38:15 AM    More...
Flexion Therapeutics to Present Phase 2b Data for FX006 at 2013 American College of Rheumatology Annual Scientific Meeting 10/2/2013 9:42:31 AM    More...
Flexion Therapeutics' Long-Lasting Steroid Injection Hits Mark in Phase 2 Trial 6/26/2013 7:48:27 AM    More...
12